Search results
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoStrong demand for Mounjaro, Zepbound, Verzenio and Jardiance pulled the top line in the quarter....
Does Medicare cover Ozempic? - WTOP News
WTOP Washington· 7 days agoAs the overall population ages, there is a growing prevalence of diabetes among adults ages 65 and older. In fact, about 16.5 million people in this age...
Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 6 days agoLilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Current ...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 6 days agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
Some Patients Suffered Psychiatric Issues After Ozempic Initiation
MedPage Today· 4 days agoSome patients who newly started a GLP-1 receptor agonist quickly developed psychiatric symptoms, a...
PlanetDrugsDirect.com Expands Access to Diabetic and Weight-Loss Medications Through Cost
Digital Journal· 1 day agoThe company is also exploring expanding its offerings to include newer GLP-1 medications such as Wegovy, Trulicity, and Victoza, anticipating similar cost reductions for these ...
Eli Lilly and Company (LLY) to Issue Quarterly Dividend of $1.30 on June 10th
ETF DAILY NEWS· 11 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) announced a quarterly dividend on Monday, May 6th, RTT News reports. Eli Lilly and Company has raised its dividend payment by an average of ...
About 79% of the S&P 500 names beat on EPS this week - Earnings
Seeking Alpha· 3 days agoA recap of the first quarter earnings week on Wall Street, highlighting the performances of big...
Considering GLP-1s: A Guide to Deciding If It's Right for You
Healthline· 2 days agoModern medicine is continually advancing treatment options for many chronic health conditions. For...